Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Agilent to Distribute Cerno's Calibration and Analysis Software with GC/MSD Systems

Published: Thursday, June 19, 2014
Last Updated: Thursday, June 19, 2014
Bookmark and Share
Novel Program Increases Lab Accuracy and Unknown Compound Identification with Single Quadrupole Instrumentation

Cerno Bioscience and Agilent Technologies, Inc. have announced Agilent will distribute Cerno Bioscience’s MassWorks™ calibration and analysis software with all Agilent GC/MSD systems. This novel calibration technology increases the mass accuracy of Agilent's single quadrupole GC/MSD to enable unknown compound identification. This process normally requires more complex instruments such as Time-of-Flight (TOF) mass spectrometers.

"Making Cerno MassWorks directly available to GC/MSD users through Agilent channels opens the qualitative power of accurate mass information to scan MS users worldwide," said Monty Benefiel, vice president and general manager of Agilent’s GC and GC/MS Solutions Division. "Through this partnership with Cerno, customers can now benefit from this new capability at an attractive incremental cost when purchasing GC/MSD systems."

MassWorks uses Cerno's patented technology to calibrate raw MS data generated by the Agilent GC/MSD systems for significantly higher mass accuracy and unparalleled spectral accuracy, enabling elemental composition determination on these otherwise conventional MS systems. In addition to enabling compound identification without a library, the MassWorks formula ID capability also speeds and adds confidence to library searches. The combination of Agilent GC/MSD and Cerno MassWorks provides an economical accurate mass formula ID solution to users who are not ready to acquire high resolution GC/MS systems.

"We are pleased to enter into this partnership with Agilent, a recognized market leader in GC/MS. Through Agilent's worldwide distribution channels, we will be able to make MassWorks broadly available to significantly more users," said Dr. Yongdong Wang, founder and president of Cerno Bioscience. "By configuring and pricing MassWorks specifically for the GC/MSD market and making the new AutoCal™ feature uniquely available on GC/MSD, we help provide a compelling solution to users who are in the market for a new GC/MS.”

MassWorks is compatible with Agilent 5977, 5975 and 5973 GC/MSD instruments running Agilent MSD ChemStation or MassHunter software.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

DEP Develops an Improved Method for First Responder Rapid Compound ID by GC/MS
The Department of Environmental Protection has demonstrated the application of Cerno Bioscience's MassWorks software for improving the accuracy and timeliness of on-site identification of unknown chemical compounds by GC/MS in time-critical environmental and homeland security incidents.
Thursday, March 13, 2008
Calibration Tutorial for Spectrometry
Cerno Bioscience has announced the availability of an online tutorial to accompany its MassWorks Clips software.
Friday, April 06, 2007
Cerno Bioscience Collaborates Lumiere Technology to Distribute MassWorks in China
Lumiere Technology’s networking will make the product available to the users in Chinese biopharmaceutical and environmental sectors.
Tuesday, January 02, 2007
Cerno Bioscience Signs Agreements with Leading Pharmaceutical Research Programs in Shanghai
Cerno Bioscience announces two major agreements have been reached with leading research institutes in China for the use of its MS data analysis software, MassWorks™.
Wednesday, October 25, 2006
Application Note Shows that Cerno's MassWorks Software Extends the Limits of Mass Spectrometry
Cerno demonstrates the ability to obtain even higher mass accuracy on quadrupole systems to further improve selectivity.
Thursday, August 24, 2006
Cerno’s Software Win Bronze Award for Most Innovative Product at PITTCON 2006
Cerno’s MassWorks figured strongly among all the nominations and won the final vote, positioned with the Bronze Award.
Friday, March 24, 2006
Scientific News
Head Injury Patients have Protein Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
Exposure to Air Pollution 30 Years Ago Associated with Increased Risk of Death
Exposure to air pollution more than 30 years ago may still affect an individual's mortality risk today, according to new research from Imperial College London.
More Then 1 in 20 U.S. Children have Dizziness and Balance Problems
Researchers at NIH have found that girls have a higher prevalence of dizziness and balance problems compared to boys, 5.7 percent and 5.0 percent.
Biosensors on Demand
New strategy results in custom "designer proteins" for sensing a variety of molecules.
Low-Cost, Portable NQR Spectroscopy
A researcher at Case Western Reserve University is developing a low-cost, portable prototype designed to detect tainted medicines and food supplements that otherwise can make their way to consumers. The technology can authenticate good medicines and supplements.
Structure of Brain Plaques in Huntington's
Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Unique Mechanism for a High-Risk Leukemia
Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!